Neonatal Seizure Registry Developmental Functional EValuation (NSR-DEV)
新生儿癫痫登记发育功能评估 (NSR-DEV)
基本信息
- 批准号:10550229
- 负责人:
- 金额:$ 103.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:5 year oldAcuteAdaptive BehaviorsAddressAgeAnticonvulsantsAntiepileptogenicBehaviorBiologicalBrainBrain InjuriesCaringCerebral PalsyChildChild DevelopmentChild RearingChildhoodClinicalCognitionCommunicationDataDevelopmentDevelopmental DisabilitiesDiagnosisEarly identificationEducationElectroencephalographyEligibility DeterminationEnrollmentEpilepsyEtiologyEvaluationEvaluation StudiesFamilyFundingFutureGestational AgeGoalsHealthImpairmentInfantInfrastructureIntellectual functioning disabilityIntelligenceInterventionIntervention StudiesInvestigationKnowledgeLeadLongterm Follow-upMeasuresMedicalMental disordersMissionModelingNatural HistoryNeonatalNervous SystemNeurodevelopmental DisabilityNeuroprotective AgentsNursery SchoolsObservational StudyOutcomeParentsPatternPediatric NeurologyPersonal SatisfactionPersonsPrognosisProviderPublic HealthRadiology SpecialtyRegistriesRegression AnalysisReportingResearchResearch DesignResearch PriorityRiskRisk FactorsSchool-Age PopulationSeizuresSeveritiesTargeted ResearchTechnologyTestingTimeUnited States National Institutes of HealthWell in selfagedanxiety symptomsclinical predictorsclinically relevantcohortdepressive symptomsdesigndisabilitydisability riskearly childhoodexecutive functionhigh riskhigh risk populationimprovedinfancyinnovationintervention programmagnetic resonance imaging/electroencephalographymethod developmentmodel buildingmodifiable riskneonatal seizureneonatenervous system disorderneurodevelopmentneuroregulationnovelpatient populationpost-traumatic stressrecruitresiliencerisk prediction modelskills
项目摘要
PROJECT SUMMARY
Neonatal seizures due to brain injury (acute symptomatic seizures) are associated with high risk of
neurodevelopmental disability in infancy. Although prognosis in early childhood is a critical question for parents
and providers, outcomes beyond infancy are largely unknown. Further, parents of infants with neonatal
seizures are at risk for mental health disorders, which can undermine their ability to care for a child with
medical complexity and may contribute to impaired child development. The proposed “Neonatal Seizure
Registry – Developmental functional EValuation (NSR-DEV)” study will test the central hypothesis that risk
factors for developmental disabilities can be identified in infancy and are modified by parent well-being.
This observational study will leverage the infrastructure of the 9 center Neonatal Seizure Registry, to which we
have recruited >300 children with acute symptomatic neonatal seizures (NCT02789176). With support for the
current proposal, this unique cohort will be available at ages 2-7 years to participate in annual validated parent-
reported developmental evaluations to characterize cognition, adaptive behavior, executive function, behavior,
epilepsy and cerebral palsy, as well as in-person, gold standard IQ testing with the WPPSI-IV at age 5 years.
Using neonatal clinical, EEG and MRI measures, as well as 3-month EEG, and longitudinal measures of parent
well-being, we will build robust models to predict developmental outcome in this high risk population.
We will test our hypotheses by pursuing the following specific aims: Aim 1a: Identify predictors of disability in
children with prior acute symptomatic neonatal seizures; Aim 1b: Examine risk factors for decline in adaptive
behavior in children with prior acute symptomatic neonatal seizures; Aim 2a: Determine whether parent well-
being (validated measures for symptoms of anxiety or depression, post-traumatic stress, and resilience) alters
the risk for disability among children with prior acute symptomatic neonatal seizures; Aim 2b: Determine
whether parent well-being alters the adaptive behavior trajectory in children with prior acute symptomatic
neonatal seizures; Aim 3: Build robust risk prediction models for childhood disability after neonatal seizures.
This innovative proposal will maintain an existing, multicenter cohort enrolled from US centers that employ
state-of-the-art technology for diagnosis and investigation of neonatal seizures, and targets research priorities
of parents and clinicians. This carefully designed study will provide novel, clinically-relevant answers to key
questions about long term outcomes in this highly vulnerable patient population. Results will inform the
subsequent design of neuromodulatory intervention studies and programs designed to optimize parent-related
factors with the goal of improving neurodevelopmental outcomes.
项目摘要
由于脑损伤引起的新生儿癫痫发作(急性症状癫痫发作)与高风险有关
婴儿期神经发育障碍。虽然幼儿期的预后是父母的关键问题
提供者和提供者,超出婴儿期的结果在很大程度上是未知的。此外,有新生儿的婴儿父母
癫痫发作有患心理健康障碍的风险,这可能会破坏他们照顾孩子的能力
医疗复杂性,可能导致儿童发展受损。拟议的“新生儿癫痫发作
注册表 - 发展功能评估(NSR-DEV)”研究将检验中心假设,即风险
可以在婴儿期确定发育障碍的因素,并通过父母的福祉来改变。
这项观察性研究将利用9个中心新生儿癫痫注册中心的基础设施,我们向此介绍
招募了300名急性症状新生儿癫痫发作的儿童(NCT02789176)。支持
当前的提案,这个独特的队列将在2-7岁的年龄上获得,参加年度验证的父母
报告的发展评估以表征认知,适应性行为,执行功能,行为,
5岁时,癫痫和脑瘫以及面对面的金标准智商测试。
使用新生儿临床,脑电图和MRI测量以及3个月的脑电图以及父母的纵向测量
幸福感,我们将建立强大的模型,以预测这个高风险人群中的发展结果。
我们将通过追求以下特定目的来检验我们的假设:目标1A:确定残疾的预测指标
先前急性症状的新生儿癫痫发作的儿童; AIM 1B:检查自适应下降的风险因素
先前急性症状的新生儿癫痫发作的儿童的行为; AIM 2A:确定父母是否有良好
存在(经过验证的动画或抑郁症状,创伤后压力和韧性)改变了
先前急性症状的新生儿癫痫发作的儿童残疾的风险; AIM 2B:确定
父母的福祉是否改变了先前急性症状的儿童的适应性行为轨迹
新生儿癫痫发作; AIM 3:在新生儿癫痫发作后为儿童残疾建立强大的风险预测模型。
该创新的提案将维护美国中心的现有多中心队列
用于诊断和调查新生儿癫痫发作的最先进技术,并针对研究优先事项
父母和临床医生。这项精心设计的研究将为关键提供新颖的,临床上的新答案
在这个高度脆弱的患者人群中,有关长期结局的问题。结果将告知
随后的神经调节干预研究和旨在优化父母相关的计划的设计
旨在改善神经发育结果的因素。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Toward Equity in Research Participation: Association of Financial Impact With In-Person Study Participation.
实现研究参与的公平:财务影响与亲自研究参与的关联。
- DOI:10.1016/j.pediatrneurol.2023.04.019
- 发表时间:2023
- 期刊:
- 影响因子:3.8
- 作者:Shellhaas,RenéeA;Lemmon,MonicaE;Gosselin,BrianN;Sturza,Julie;Franck,LindaS;Glass,HannahC;NeonatalSeizureRegistry
- 通讯作者:NeonatalSeizureRegistry
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hannah Cranley Glass其他文献
Hannah Cranley Glass的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hannah Cranley Glass', 18)}}的其他基金
NSR-GENE (Neonatal Seizure Registry, GEnetics of post-Neonatal Epilepsy)
NSR-GENE(新生儿癫痫登记,新生儿后癫痫遗传学)
- 批准号:
10464355 - 财政年份:2022
- 资助金额:
$ 103.58万 - 项目类别:
NSR-GENE (Neonatal Seizure Registry, GEnetics of post-Neonatal Epilepsy)
NSR-GENE(新生儿癫痫登记,新生儿后癫痫遗传学)
- 批准号:
10580043 - 财政年份:2022
- 资助金额:
$ 103.58万 - 项目类别:
Neonatal Seizure Registry Developmental Functional EValuation (NSR-DEV)
新生儿癫痫登记发育功能评估 (NSR-DEV)
- 批准号:
10330599 - 财政年份:2020
- 资助金额:
$ 103.58万 - 项目类别:
Neonatal Seizure Registry Developmental Functional EValuation (NSR-DEV)
新生儿癫痫登记发育功能评估 (NSR-DEV)
- 批准号:
9887172 - 财政年份:2020
- 资助金额:
$ 103.58万 - 项目类别:
HEAL - EEG - Neurophysiologic measures of Epo treatment for hypoxic-ischemic encephalopathy (HIE)
HEAL - 脑电图 - Epo 治疗缺氧缺血性脑病 (HIE) 的神经生理学措施
- 批准号:
10200910 - 财政年份:2018
- 资助金额:
$ 103.58万 - 项目类别:
HEAL - EEG - Neurophysiologic measures of Epo treatment for hypoxic-ischemic encephalopathy (HIE)
HEAL - 脑电图 - Epo 治疗缺氧缺血性脑病 (HIE) 的神经生理学措施
- 批准号:
9790993 - 财政年份:2018
- 资助金额:
$ 103.58万 - 项目类别:
MRI Mechanisms of Adverse Outcome in Preterm Infants with Seizures
早产儿癫痫发作不良后果的 MRI 机制
- 批准号:
8290057 - 财政年份:2010
- 资助金额:
$ 103.58万 - 项目类别:
MRI Mechanisms of Adverse Outcome in Preterm Infants with Seizures
早产儿癫痫发作不良后果的 MRI 机制
- 批准号:
8037069 - 财政年份:2010
- 资助金额:
$ 103.58万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Beat Extreme: An Interactive, Tailored Text Messaging Program Combining Extreme Weather Alerts with Hyper-localized Resources & Actionable Insights for Addressing Climate Change
Beat Extreme:一款将极端天气警报与超本地化资源相结合的交互式定制短信程序
- 批准号:
10698887 - 财政年份:2023
- 资助金额:
$ 103.58万 - 项目类别:
Identifying mechanisms ofsynapse maturation at neuronal subtype resolution
识别神经元亚型分辨率下突触成熟的机制
- 批准号:
10739241 - 财政年份:2023
- 资助金额:
$ 103.58万 - 项目类别:
Connecting Alcohol Myopia to Real-World Risk Behaviors through Cognitive Ecological Momentary Assessment
通过认知生态瞬时评估将酒精近视与现实世界的风险行为联系起来
- 批准号:
10452909 - 财政年份:2022
- 资助金额:
$ 103.58万 - 项目类别:
Limbic Pallidum DBS for the treatment of severe alcohol use disorder
边缘苍白球 DBS 用于治疗严重酒精使用障碍
- 批准号:
10539383 - 财政年份:2022
- 资助金额:
$ 103.58万 - 项目类别: